Indeed, a significant increase in L-type amino acid transporter 1 (LAT1) expression has been determined in glioma; such increase has been found to correlate with gliomas [18F]DOPA uptake both in vitro and in vivo [75]. This evidence concerns the gene SLC7A5 and central nervous system cancer.